Hikma Pharmaceuticals Plc Debt/Equity Ratio 2016-2024 | HKMPF
- Hikma Pharmaceuticals Plc average debt/equity ratio for 2023 was 0.49, a 7.55% decline from 2022.
- Hikma Pharmaceuticals Plc average debt/equity ratio for 2022 was 0.53, a 70.97% decline from 2021.
- Hikma Pharmaceuticals Plc average debt/equity ratio for 2021 was 0.31, a 20.51% increase from 2020.
Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.